CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3023% above fair value
$79.81−1.36 (-1.68%)
Close on Nov 12, 2026Market cap $4.19BP/E 33.4Yield –
CareDx ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
CareDx's ebitda for the twelve months ending Sep 30, 2026 was $134.29M, up 81.1% year over year. For fiscal 2025 it was -$15.76M, down 128.7% from the year before. The highest annual figure on record is $54.96M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.76M | -128.7% |
| FY2024 | Dec 31, 2024 | $54.96M | – |
| FY2023 | Dec 31, 2023 | -$188.98M | – |
| FY2022 | Dec 31, 2022 | -$65.64M | – |
| FY2021 | Dec 31, 2021 | -$20.93M | – |
| FY2020 | Dec 31, 2020 | -$15.52M | – |
| FY2019 | Dec 31, 2019 | -$19.01M | – |
| FY2018 | Dec 31, 2018 | -$11.36M | – |
| FY2017 | Dec 31, 2017 | -$16.57M | – |
| FY2016 | Dec 31, 2016 | -$34.41M | – |
| FY2015 | Dec 31, 2015 | -$11.14M | -732.0% |
| FY2014 | Dec 31, 2014 | $1.76M | – |
| FY2013 | Dec 31, 2013 | -$194.00K | – |
| FY2012 | Dec 31, 2012 | -$1.27M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $15.32M | +329.3% |
| Q2 FY2026 | Jun 30, 2026 | $116.03M | – |
| Q1 FY2026 | Mar 31, 2026 | $5.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.16M | -102.5% |
| Q3 FY2025 | Sep 30, 2025 | $3.57M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.40M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.77M | – |
| Q4 FY2024 | Dec 31, 2024 | $87.74M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.25M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$18.75M | – |
| Q4 FY2023 | Dec 31, 2023 | -$119.00M | – |
| Q3 FY2023 | Sep 30, 2023 | -$25.12M | – |
| Q2 FY2023 | Jun 30, 2023 | -$23.96M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.90M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.91M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.31M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.98M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.43M | -1604.9% |
| Q4 FY2021 | Dec 31, 2021 | -$12.90M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.53M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.59M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.09M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.11M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.10M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.17M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.13M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.86M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.29M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.63M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.24M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.24M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.71M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.22M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.20M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.30M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.95M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.71M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.61M | – |
| Q4 FY2016 | Dec 31, 2016 | -$18.14M | – |
See a number that looks wrong?